RAIsonance Submits EUA Application to FDA for AudibleHealth Dx

GREENWOOD VILLAGE, Colo., Sept. 27, 2022 /PRNewswire/ — RAIsonance, Inc., today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its AudibleHealth Dx Software as a Medical Device (SaMD). The device is…

Click here to view original post